• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.45% Nasdaq Up 0.08%

    More On BNVIQ

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    Bionovo, Inc. (BNVIQ)

    -Other OTC
    0.00 0.00(0.00%) Jul 28
    Add to Portfolio
    Prev Close:0.00
    Open:0.00
    Bid:N/A
    Ask:N/A
    1y Target Est:5.00
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.00 - 0.00
    Volume:0
    Avg Vol (3m):19,803
    Market Cap:64.26K
    P/E (ttm):N/A
    EPS (ttm):-0.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for BNVIQ at this time.

    Comparison

    Symbol% ChgMkt Cap
    BNVIQ 0.00%64.26K
    AZNUp 0.12%41.52B
    BMYDown 0.31%107.49B
    PFEUp 1.36%220.63B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):0.26
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Bionovo, Inc., a pharmaceutical company, is focused on the discovery and development of drugs for the treatment of unmet medical needs in womenÂ’s health and cancer in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback